These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 11454808

  • 1. Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis.
    Mitchell SA, Grove J, Spurkland A, Boberg KM, Fleming KA, Day CP, Schrumpf E, Chapman RW, European Study Group of Primary Sclerosing Cholangitis.
    Gut; 2001 Aug; 49(2):288-94. PubMed ID: 11454808
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The interleukin-1 and interleukin-10 gene polymorphisms in primary sclerosing cholangitis: no associations with disease susceptibility/resistance.
    Donaldson PT, Norris S, Constantini PK, Bernal W, Harrison P, Williams R.
    J Hepatol; 2000 Jun; 32(6):882-6. PubMed ID: 10898307
    [Abstract] [Full Text] [Related]

  • 4. Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population.
    Neri TM, Cavestro GM, Seghini P, Zanelli PF, Zanetti A, Savi M, Podda M, Zuin M, Colombo M, Floreani A, Rosina F, Bianchi Porro G, Strazzabosco M, Okolicsanyi L.
    Dig Liver Dis; 2003 Aug; 35(8):571-6. PubMed ID: 14567462
    [Abstract] [Full Text] [Related]

  • 5. Polymorphisms in tumour necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and -DQ alleles and subclinical markers.
    Hirv K, Seyfarth M, Uibo R, Kull K, Salupere R, Latza U, Rink L.
    Scand J Gastroenterol; 1999 Oct; 34(10):1025-32. PubMed ID: 10563674
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour?
    Louis E, Peeters M, Franchimont D, Seidel L, Fontaine F, Demolin G, Croes F, Dupont P, Davin L, Omri S, Rutgeerts P, Belaiche J.
    Clin Exp Immunol; 2000 Jan; 119(1):64-8. PubMed ID: 10606965
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene.
    Ho SY, Wang YJ, Chen HL, Chen CH, Chang CJ, Wang PJ, Chen HH, Guo HR.
    Cancer Causes Control; 2004 Sep; 15(7):657-63. PubMed ID: 15280623
    [Abstract] [Full Text] [Related]

  • 11. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study.
    Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmati F, Cheval C, Monchi M, Teboul JL, Riché F, Leleu G, Arbibe L, Mignon A, Delpech M, Dhainaut JF.
    JAMA; 1999 Aug 11; 282(6):561-8. PubMed ID: 10450718
    [Abstract] [Full Text] [Related]

  • 12. Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C.
    Hov JR, Lleo A, Selmi C, Woldseth B, Fabris L, Strazzabosco M, Karlsen TH, Invernizzi P.
    J Hepatol; 2010 May 11; 52(5):712-7. PubMed ID: 20347497
    [Abstract] [Full Text] [Related]

  • 13. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles.
    Wiencke K, Spurkland A, Schrumpf E, Boberg KM.
    Hepatology; 2001 Oct 11; 34(4 Pt 1):625-30. PubMed ID: 11584356
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis.
    Cookson S, Constantini PK, Clare M, Underhill JA, Bernal W, Czaja AJ, Donaldson PT.
    Hepatology; 1999 Oct 11; 30(4):851-6. PubMed ID: 10498633
    [Abstract] [Full Text] [Related]

  • 16. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
    Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broomé U, Schreiber S, Boberg KM.
    Am J Gastroenterol; 2007 Jan 11; 102(1):115-21. PubMed ID: 17100974
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative genetic association of human leukocyte antigen class II and tumor necrosis factor-alpha with dermatitis herpetiformis.
    Wilson AG, Clay FE, Crane AM, Cork MJ, Duff GW.
    J Invest Dermatol; 1995 May 11; 104(5):856-8. PubMed ID: 7738367
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Polymorphisms in tumour necrosis factor alpha, interleukin-10 and transforming growth factor beta1 genes and end-stage liver disease.
    Bathgate AJ, Pravica V, Perrey C, Hayes PC, Hutchinson IV.
    Eur J Gastroenterol Hepatol; 2000 Dec 11; 12(12):1329-33. PubMed ID: 11192323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.